# Aquestive Therapeutics, Inc.: Form 8-K, filed May 13, 2026

- Company: [Aquestive Therapeutics, Inc.](/companies/aqst.md) (CIK 1398733)
- Form: 8-K
- Filed: 2026-05-13
- Accepted by EDGAR: May 13, 2026, 16:04 ET
- Period: 2026-05-12
- Accession: 0001398733-26-000029
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1398733/000139873326000029/aqst-20260512.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1398733/000139873326000029/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.02: Results of operations
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1398733/000139873326000029/aqst-20260512.htm

Filed May 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001398733-26-000029. Last ingested by Listed: Nov 13, 2026, 16:06 ET. No prices; not investment advice.
